Clara Rosso-Fernández

Author

Hospital Universitario Virgen del Rocío ORCID

Also Known As

C. García-Calderón, C. M. Rosso-Fernandez, C. Rosso-Fernández, C.M. Rosso-Fernández, Clara M Rosso-Fernández, Clara M. Rosso, Clara M. Rosso-Fernández, Clara María Rosso-Fernández, Clara Rosso Fernández, Clara Rosso-Fernandez

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen del Rocío Universidad de Sevilla Hospital Universitario Virgen Macarena Instituto de Biomedicina de Sevilla Bellvitge University Hospital

About

Clara Rosso-Fernández is an author at Hospital Universitario Virgen del Rocío specializing in medicine, antimicrobial stewardship, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	400
2	Antibiotics	3	3	378
3	Public Health	1	1	22
4	Epidemiology	1	1	22
5	Hospital Medicine	1	1	22

Clara Rosso-Fernández

Publications

902

Citations

H-Index

Page 1

	Year	Citations
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial Manuela Aguilar‐Guisado, Ildefonso Espigado, Almudena Martín‐Peña, The Lancet Haematology AntibioticsAntimicrobial StewardshipPhase 4Empirical Antimicrobial TherapyClinical Trials	2017	230
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial José Molina, Enrique Montero-Mateos, Julia Praena‐Segovia, Clinical Microbiology and Infection Antimicrobial StewardshipAntibioticsHealthcare-associated InfectionBloodstream InfectionsSeven-versus 14-Day Course	2021	125
Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1–2, a Randomized Controlled Clinical Trial Elisa Cordero, Cristina Roca-Oporto, Ángel Bulnes‐Ramos, Clinical Infectious Diseases	2017	118
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study Oliver A. Cornely, José Miguel Cisneros, Julián Torre‐Cisneros, Journal of Antimicrobial Chemotherapy	2019	115
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant <i>Escherichia coli</i> Bacteremic Urinary Tract Infections Jesús Sojo-Dorado, Inmaculada López-Hernández, Clara Rosso-Fernández, JAMA Network Open	2022	82
Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing <i>Escherichia coli</i> (FOREST): study protocol for an investigator-driven randomised controlled trial Clara Rosso-Fernández, Jesús Sojo-Dorado, Ángel Díaz Barriga, BMJ Open	2015	65
Tuberculosis Prophylaxis With Levofloxacin in Liver Transplant Patients Is Associated With a High Incidence of Tenosynovitis: Safety Analysis of a Multicenter Randomized Trial Julián Torre-Cisneros, Rafael San Juan, Clara Rosso-Fernández, Clinical Infectious Diseases	2015	59
Long-term disability after lacunar stroke Mandip S. Dhamoon, Leslie A. McClure, Carole L. White, Neurology	2015	38
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial Luis Eduardo López-Cortés, Mercedes Delgado-Valverde, Elisa Moreno-Mellado, The Lancet Infectious Diseases Structured De-escalationAntimicrobial SusceptibilityAntimicrobial StewardshipAntibioticsBloodstream Infections	2024	23
Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study Sonsoles Salto‐Alejandre, Silvia Jiménez‐Jorge, Núria Sabé, PLoS ONE Solid Organ RecipientsSolid Organ TransplantationTransplantation MedicineCovid-19Hospital Medicine	2021	22

Page 1